Business
4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.
About this update from 4dmedical Ltd.
[{"type":"text","content":"Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more","length":213,"tagName":"p","attribs":{}},{"type":"text","content":"LOS ANGELES and MELBOURNE, Australia, Jan. 26, 2026 /PRNewswire/ -- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.","length":456,"tagName":"p"},{"type":"image","alt":"Backed by new institutional funding, 4DMedical is advancing its respiratory imaging technology and expanding the U.S. rollout of its FDA-cleared CT:VQ™ software. (PRNewsfoto/4DMedical)","displaySize":"","headline":null,"caption":"Backed by new institutional funding, 4DMedical is advancing its respiratory imaging technology and expanding the U.S. rollout of its FDA-cleared CT:VQ™ software. (PRNewsfoto/4DMedical)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/18ccef0685f4ab9361afea17a5a2250c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/T2wmafw3Qr.IXJrciiFhNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/18ccef0685f4ab9361afea17a5a2250c","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2869983/4DMedical_Respiratory_Imaging.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"CT:VQ™ is 4DMedical's FDA-cleared, SaaS technology that provides ventilation and perfusion insights from CT imaging. Within just four months of FDA clearance, CT:VQ was deployed by four elite U.S. academic medical centers: Stanford, Cleveland Clinic, University of Miami, and UC San Diego Health. These rapid adoptions reflect growing interest from clinicians seeking quantified, actionable and functional information not available from traditional imaging--but increasingly vital to support diagnosis, treatment planning, and longitudinal monitoring.","length":555,"tagName":"p"},{"type":"text","con...